Friday, March 20, 2015 9:32:25 AM
Anyway, this should give direction to your search:
http://www.prnewswire.com/news-releases/oxis-biotech-executes-worldwide-exclusive-patent-licensing-p62-chemical-agents-and-multiple-myeloma-therapeutics-with-dr-xiang-qun-sean-xie-professor-of-pharmaceutical-sciences-at-university-of-pittsburgh-300018823.html
http://www.cbligand.org/xielab/research.php
Did not know solubility was a problem, but most drugs are, right?
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM